Agilent Meets EU Conditions for Varian Purchase

The $1.5 billion acquisition was announced almost a year ago, but its completion has been held up by regulatory bodies in the US and EU.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories